Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Men with androgenetic alopecia do not have elevated DHEA-S levels.

New skin treatments in 1987-1988 showed effectiveness for various conditions, but some had side effects or risks.

Topical finasteride is promising for hair loss with minimal side effects but needs more research and approval.

Caffeine can potentially treat common hair loss by counteracting hair follicle shrinkage caused by hormones.

Men with male pattern baldness don't necessarily have high levels of Dehydroepyandrosterone-sulfate, and there's no link between its levels and the severity of hair loss.

New treatment improves male hair loss.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

New treatments for male hypogonadism are effective and should be personalized.

Suppressing certain hormones might help prevent prostate cancer.

Blocking the enzyme 5α-reductase can shrink the prostate and help treat enlarged prostate issues.

5α-reductase inhibitors, like Finasteride and Dutasteride, help manage benign prostatic hyperplasia.

Blocking the enzyme that turns testosterone into DHT can safely and effectively treat enlarged prostate.

Spironolactone reduced hair thickness and some testosterone levels in women with excessive hair growth.

5 alpha-reductase inhibitors, like finasteride, are used to treat conditions like prostate issues and skin disorders.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction, but the exact reasons are unclear.

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

CAG repeat polymorphism and prostate zone volume are not reliable markers of long-term androgen sensitivity.

Differences in enzyme activity and androgen receptors in hair follicles may explain why hair loss appears differently in men and women.

The conclusion is that future hair loss treatments should target the root causes of hair thinning, not just promote hair growth.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Clascoterone cream was approved in the USA for treating acne in people aged 12 and older.

The substance MK386 effectively blocked testosterone conversion and reduced cell growth in certain skin cells, but inhibiting 5α-reductase alone may not greatly improve acne.

A stronger dual 5α-reductase inhibitor could improve treatment for benign prostatic hyperplasia by further reducing DHT levels.

Finasteride reduces caspase levels, helping hair growth in AGA patients.

Both dutasteride and finasteride improve urinary symptoms, but dutasteride may be better at reducing the risk of prostate surgery and sudden inability to urinate.

A new supplement may treat hair loss by targeting multiple causes like inflammation and stress.

Perilla frutescens is a versatile herb with health benefits and potential in food and industrial uses.

Finasteride caused enlarged breast tissue in a 62-year-old man.